Patent · US Active

Nanoparticles containing extracellular matrix for drug delivery

US11491115B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 8, 2016
Grant dateNov 8, 2022
Priority date
Expiry dateJul 24, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y302/01031
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nanoparticles coated with extracellular matrix (ECM) are provided, in some aspects, for the delivery of a therapeutic protein, nucleic acid, or drug. In some embodiments, the nanoparticles are delivered to a subject via inhalation or aerosol delivery. Also provided, in some aspects, are methods for treating acute lung injury comprising administering α-Klotho (αKlotho) protein or DNA to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.